Monday Presentations

Monday, March 17, 2008

7:30 am–9:30 am Oncologic Interventions: Kidney (CC) Ballroom C

9:00 am Monitoring Outcomes after Renal Ablation: Imaging and Survival Stephen B. Solomon, MD 9:15 am Panel Discussion

Coordinator: Debra Ann Gervais, MD

This course is the second course in the New Developments in Oncologic Interventions series. The focus of this course is on the modern management of Renal Cell Carcinoma (RCC). Presentations will cover our current understanding of the epidemiology and staging of RCC as well as the established role for medical and urologic management. Emphasis will be placed on published outcomes of percutaneous ablation, methods for monitoring ablation outcomes, controversies in management and prevention of complications.

1. Review the current and evolving therapeutic pathways for primary and metastatic renal cell carcinoma 2. Identify the advantages and disadvantages of cryoablation and radiofrequency ablation as applied to treatment of renal masses 7:30 am Clinical Overview, Subtypes, and Staging of RCC Surena Matin, MD 7:45 am New Developments in the Medical Management of RCC Roberto Pili, MD 8:00 am New Developments in the Urologic Management of RCC Surena Matin, MD 8:15 am Percutaneous Ablation: Reported Outcomes and Changes in Practice Kamran Ahrar, MD 8:30 am Controversies in Renal Ablation Technology and Approach William Charboneau, MD 8:45 am Prevention and Management of Complications Following Ablation of Renal Masses Debra Ann Gervais, MD

Coordinator: Alan H. Matsumoto, MD, FSIR

This year at the Annual Meeting we will initiate a Case-based Review (CBR) series of eight topicoriented categorical courses. These 2-hour sessions will cover a broad range of material from Vascular Diagnosis to Venous and Arterial Vascular Interventions. In each session, three or four expert faculty will present three or four cases each (for a total of 10-12 unknowns) that illustrate the full range of interventions in that topic area. Faculty will present cases that challenge the diagnostic acumen or technical and medical knowledge of the learner. A handout will be prepared for each course that summarizes the important learning points of each case and provides references for further reading.

MONDAY

Objectives—At the end of this session, the learner should be able to:

7:30 –9:30 am Case-based Review: Peripheral Arterial Interventions (CC) Ballroom AB

Based on the specific topic, at the end of the session the learner should be able to: 1. Identify key diagnostic imaging findings of selected vascular pathologic conditions 2. List appropriate patient selection factors for arterial and venous vascular interventions 3. Describe expected complications of vascular and non-vascular interventions 4. Illustrate simple and complex treatment strategies for arterial and venous diseases 5. Relate key technical aspects of vascular and non-vascular interventional procedures 7:30 am Cases 1-3 Alan H. Matsumoto, MD, FSIR 8:00 am Cases 4-6 Michael D. Dake, MD 8:30 am Cases 7-9 Bulent Arslan, MD 9:00 am Cases 10-12 Clement J. Grassi, MD, FSIR P9

7:30 am–9:30 am Advances in Clinical Care: Periprocedural Clinical Management (CC) Room: 207B Coordinator: Pater N. Waybill, MD

Coordinator: Ziv J Haskal, MD, FSIR, FACR, FAHA

In this course we review new strategies for the management of patients before and after IR procedures. This course will focus on issues of common interest to interventional radiologists and nurse practitioners including antibiotics, contrast, sedation, blood pressure control and organ failure.

The image-guided revolution of IR has changed the practice of medicine around the world. This year, the SIR Annual Scientific Meeting continues its tradition of highlighting the global nature of the field by focusing on innovations and research from Latin America.

Objectives—At the end of the session, the learner should be able to:

In this Plenary session, we explore the practice of image-guided interventions represented by experts from the many countries of Latin America. Join us for the illuminating perspectives that may change your IR practice and provide you insights into the next generation of endovascular evolution.

1. Describe the broad categories of antibiotics used in IR and indications for particular procedural applications 2. Cite complications of gadolinium and symptoms associated with nephrogenic fibrosing sclerosis (NFS) 3. Describe strategies for preventing infection in the IR suite 4. List key medications used in IR to control procedure-related blood pressure aberrations 5. Categorize medications available for moderate conscious sedation and describe potential adverse side effects or complications from these medications. 7:30 am Update on Strategies for Preventing Infection in the IR Suite Anthony D. Goei, MD 7:50 am Antibiotic use in the Periprocedural Management of IR cases Andrew Robert Forauer, MD 8:10 am Alternative Contrast Agents in IR—Indications and Risks Hyun S. ’Kevin’ Kim, MD 8:30 am Management of Sedation in the IR Suite Leslie B. Scorza, MD 8:55 am Periprocedural Management of Hypertension and Hypotension Edward Liszka, MD 9:20 am Questions P10

10:00 am–12:00 pm SIR Meets Latin America & Dotter Lecture (PL) Ballroom AB

Objectives—At the end of this session, the learner should be able to: 1. Describe innovations in interventional technique devised by practitioners in Latin America 2. Identify novel practice models for image-guided procedures in Latin America 3. Recognize medical conditions unique to Latin America that have benefited from interventional management 4. Discuss the common bonds of practice that join the global community of IR 10:00 am Introduction Ziv J Haskal, MD, FSIR, FACR, FAHA 10:00 am Stem Cells in Parkinson’s Disease: Endovascular Delivery (Peru) Augusto Brazzini, MD 10:10 am Results of Venous Laser Ablation in ⬎2000 cases (Venezuela) Moises Roizental, MD 10:20 am Coronary Artery Interventions by the Interventional Radiologist (Mexico) Francisco Gonzalez-Loya, MD 10:30 am Novel IR Practice Models and UFE (Brazil) Nestor H. Kisilevzky, MD 10:40 am Results of renal artery aneurysm embolization with novel agents (Brazil) Carlos G.C. Abath, MD

10:50 am Utero-vesical anastomosis and implications for UFE: An anatomic study (Argentina) Ricardo D. Garcia-Monaco, MD 11:00 am Biliary Interventions in treatment of benign biliary strictures (Argentina) Mariano E. Gimenez, MD 11:10 am Novel AAA device development: Benchtop to Bedside (Chile) Mario P. Fava, MD 11:20 am Dotter Lecture Can IR Survive without Scientific Evidence? Jim A. Reekers, MD

2:00 pm Treatment of type II endoleaks Chieh-Min Fan, MD 2:15 pm Debate: Healthy 65 year old male with “chip shot” 6 cm AAA: EVAR? James F. Benenati, MD, FSIR and Alan H. Matsumoto, MD, FSIR 2:40 pm Mycotic aneurysms * ok to EVAR? Mahmood K. Razavi, MD 2:50 pm Resectable Cancer and AAA: Which to treat first? Luiz Correa, MD

1:00 pm–3:00 pm Devices Seminar: Embolization Agents (CC) Room: 207B

MONDAY

1:00 pm–3:00 pm Advances in Endovascular Aneurysm Repair (CC) Ballroom C

1:45 pm The best way to follow a patient after EVAR is . . .? S. William Stavropoulos, MD, FSIR

Coordinator: John A. Kaufman, MD, FSIR

Considerable recent progress has been made in the endovascular treatment of aortic aneurysms. Device design has improved and our understanding of processes leading to technical failure has increased. In this course, we present the latest available information on technical improvements and clinical results for management of aortic aneurysm in both the chest and abdomen. Objectives—At the end of this session, the learner should be able to:

Coordinators: Jafar Golzarian, MD & Jeanne LaBerge, MD, FSIR

The practice of interventional radiology today requires that practitioners use a wide variety of medical devices in a variety of clinical settings. Understanding and mastering the use of all available devices is a daunting task. The IR Devices Seminar is an attempt to organize information about medical devices used in Interventional radiology in a way that makes the material more readily accessible and understandable.

1. Describe the pros and cons of repair of small aneurysms 2. Describe and differentiate the varied strategies for follow-up after EVAR 3. Describe the indications and timing for secondary interventions for endoleaks 4. Describe the different management options for mycotic aortic aneurysms 5. Describe novel uses of endografts for treatment of unusual aortic pathologies

In this course, we will describe and categorize the common tools used for arterial embolization. Key characteristics of embolization agents and delivery systems will be reviewed and features suitable to specific clinical or technical situations will be presented.

1:00 pm Access: It all starts here John A. Kaufman, MD, FSIR

1. List key characteristics of microcatheters as they relate to both peripheral and neurointerventional applications 2. Describe mechanisms for deployment of detachable coils 3. Explain circumstances in which a stent graft can be used as an occlusive device 4. Describe the compositional and functional differences between spherical and non-spherical embolization agents 5. Classify embolization agents according to their physical properties

1:10 pm De-branches, windows, or branches Roy Greenberg, MD 1:25 pm Debate: EVAR outcomes: The device does matter in 2008 Robert A. Morgan, MD, Chet R. Rees, MD, FSIR

Objectives—At the end of this session, the learner should be able to:

P11

1:00 pm Introduction Jeanne M. LaBerge, MD, FSIR 1:05 pm Microcatheter in Peripheral Michael D. Darcy, MD, FSIR 1:17 pm Microcatheter from Neuro-Interventional David A. Kumpe, MD, FSIR

Based on the specific topic, at the end of the session the learner should be able to:

1:41 pm Coils: Detachable Keigo Osuga, MD

1. Identify key diagnostic imaging findings of selected vascular pathologic conditions 2. List appropriate patient selection factors for arterial and venous vascular interventions 3. Describe expected complications of vascular and non-vascular interventions 4. Illustrate simple and complex treatment strategies for arterial and venous diseases 5. Relate key technical aspects of vascular and non-vascular interventional procedures

1:52 pm Plugs and Occluders Frederick S. Keller, MD, FSIR

1:00 pm Cases 1-3 Gavin W. Britz, MD

1:29 pm Pushable Coils Robert I. White Jr., MD, FSIR

2:04 pm Stentgraft as an Occlusive Device Marc R. Sapoval, MD 2:16 pm Non-spherical PVA: From A to Z Gary P. Siskin, MD, FSIR 2:28 pm Spherical Agents Jafar Golzarian, MD 2:40 pm Drug-Eluting Beads Jeff H. Geschwind, MD, FSIR 2:52 pm Temporary Agents Ziv J Haskal, MD, FSIR, FACR, FAHA

1:00 –3:00 pm Case-based Review: Neurovascular Interventions (CC) Ballroom AB Coordinator: Tony P. Smith, MD, FSIR

This year at the Annual Meeting we will initiate a Case-based Review (CBR) series of eight topicoriented categorical courses. These 2-hour sessions will cover a broad range of material from Vascular Diagnosis to Venous and Arterial Vascular Interventions. In each session, three or four expert faculty will present three or four cases each (for a total of 10-12 unknowns) that illustrate the full range of interventions in that topic area. Faculty will present cases that challenge the diagnostic acumen or technical and medical knowledge of the P12

learner. A handout will be prepared for each course that summarizes the important learning points of each case and provides references for further reading.

1:45 pm Cases 4-6 Ali Zomorodi, MD 2:15 pm Cases 7-9 Tony P. Smith, MD, FSIR

4:00 – 6:00 pm Endovascular Intervention: Now and in the Future (PL) Ballroom AB Coordinator: Michael D. Dake, MD

The past decade has seen tremendous advances in our understanding of vascular disease, and this knowledge has lead to the development of numerous innovative treatments for cardiovascular disease. But great unsolved mysteries remain. In this session, Michael Dake, MD and his faculty will explore what we do not know about vascular disease and how new and innovative strategies may emerge from successful inquiry into these areas. At the end of this session, the learner should be able to: 1. List the limitations of current endovascular therapies in management of occlusive and aneurymal disease 2. Discuss new research avenues for imaging and treating vascular pathology at the cellular and molecular level 3. Identify key areas for improvement of existing endovascular technology

4:00 pm Transcatheter Embolization Marshall Hicks, MD, FSIR

5:01 pm Malignant Disease Reed A. Omary, MD, MS, FSIR

4:12 pm Thrombolysis/clot Management Suresh Vedantham, MD

5:13 pm Arterial occlusive disease Barry T. Katzen, MD, FSIR

4:24 pm Peripheral Arterial Interventions Timothy P. Murphy, MD 4:36 pm Aortic Endograft Therapy David M. Williams, MD, FSIR 4:49 pm Venous Disease Ziv J Haskal, MD, FSIR, FACR, FAHA

5:25 pm Aortic disease Roy Greenberg, MD 5:37 pm Stroke Colin Derdeyn, MD 5:49 pm Interventional Regenerative Medicine with Molecular and Cellular Image-Guided Therapies Lindsay Machan, MD, FSIR

MONDAY

P13